Shifting Paradigms for Suppressing Fibrosis in Kidney Transplants: Supplementing Perfusion Solutions With Anti-fibrotic Drugs.

van Leeuwen, L Leonie; Leuvenink, Henri G D; Olinga, Peter; Ruigrok, Mitchel J R

van Leeuwen, L Leonie; Leuvenink, Henri G D; Olinga, Peter; Ruigrok, Mitchel J R.

Afiliación

van Leeuwen LL; Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Leuvenink HGD; Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Olinga P; Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, Netherlands.
Ruigrok MJR; Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, Netherlands.

Front Med (Lausanne) ; 8: 806774, 2021.

Article en En | MEDLINE | ID: mdl-35083254

Palabras clave

IF/TA; IRI; donation after circulatory death (DCD); machine perfusion; personalized medicine; precision cut tissue slices; renal transplantation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Med (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google